Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Pharmaceutical Services × Clear all

Phase

Status

Sponsor Class

OTHER 4 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumor, Adult 1

Interventions

Cisplatin 43 Capecitabine 40 Radiotherapy 31 Gemcitabine 31 Paclitaxel 30 Oxaliplatin 30 Drug Therapy 29 Cyclophosphamide 29 Carboplatin 28 apatinib 27 tislelizumab 25 Irinotecan 25 Docetaxel 25 Fluorouracil 24 Bevacizumab 23 Surgical Procedures, Operative 19 Nivolumab 18 pembrolizumab 17 fludarabine 16 Metformin 16 Radiation 15 Exercise 15 camrelizumab 14 Blood Specimen Collection 14 S 1 (combination) 13 Control Groups 12 Neoadjuvant Therapy 11 Trastuzumab 10 Standard of Care 10 Pemetrexed 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04175899 2021-03-08

POCCP1

Ministry of Health, Malaysia

Phase NA Unknown

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡